RHOLONDA ADAMS: Open Payments
NPI 1407571425 · MILTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 10 payments from 3 companies in 2025. Trend: 2023 $944 · 2024 $237 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 8 | $189 |
| Neurocrine BioSciences, Inc. | 1 | $126 |
| ABBVIE INC. | 1 | $16 |
Products named: Qelbree, INGREZZA, VRAYLAR.
Industry payments across GA — which companies pay providers there.
